Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis;Botulinum toxin typ A in der behandlung der adduktorenspastizität

Wiener Klinische Wochenschrift, Supplement

Volumn 113, Issue 4, 2001, Pages 20-24

  Wissel, J ^a   Entner, T ^a  

^a Universitatsklinik fur Neurochirurgie Innsbruck   (Austria)

Author keywords

Adducor spasticity; Botulinumtoxin; Rating scales

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; SPASMOLYTIC AGENT;

BLEPHAROSPASM; CLOSTRIDIUM BOTULINUM; DISEASE SEVERITY; DOSE RESPONSE; DRUG APPROVAL; DRUG INDUCED DISEASE; DRUG ISOLATION; DRUG MECHANISM; DYSTONIA; GAIT DISORDER; HIP; HUMAN; HYGIENE; INJECTION; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; MUSCLE SPASM; MYALGIA; PASSIVE MOVEMENT; PHYSIOTHERAPY; REVIEW; SPASTICITY;

ADULT; BOTULINUM TOXIN TYPE A; CONTROLLED CLINICAL TRIALS; DOUBLE-BLIND METHOD; HIP JOINT; HUMANS; INJECTIONS, INTRAMUSCULAR; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES; PLACEBOS; RANGE OF MOTION, ARTICULAR; TIME FACTORS; TREATMENT OUTCOME; WALKING;

EID: 0034749263     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
2. Treatment of spasticity with botulinum toxin: A double-blind study
3. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: A randomized, double-blind study of "high-dose" versus "low-dose" treatment
4. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport®) with placebo in upper limb spasticity after stroke
5. Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms
6. Botulinum Toxin for the treatment of spasticity in multiple sclerosis
7. Botulinum toxin for spasms and spasticity in the lower extremities
8. Botulinum Toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: A randomised, double blind, placebo controlled, dose rating study
9. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients
10. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: A randomized, double-blind, placebo-controlled trial
11. Interrater reliability of a modified Ashworth scale of muscle spasticity
12. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness